Polybrominated dibenzo-p-dioxins and dibenzofurans: literature review and health assessment. by Mennear, J H & Lee, C C
EnvironmentalHealth Perspectives Supplements
Vol. 102 Suppl1:265-274 1994
Polybrominated Dibenzo-p-Dioxins and
Dibenzofurans: Literature Review and
Health Assessment
by John H. Mennear and Cheng-Chun Lee2
Nlybrominateddibenzo-p-dioxins (PBDDs)anddibenzolurans (PBDFs)occurastrace(ppb)contaminantsinbrominated
flame retardants and areproducedduringcombustion ofthesechemicals. Theyarealsoformedwhenorganicsarein-
cinerated inthepresenceofbromine, e. g.,inmunicipalandindustrial incineratorsandininternal-combustionengines.
Combustion oforganics in the presence ofboth bromine and chlorine results in the formation ofmixed (ie., bromo,
bromo/chloroandchloro) halogenateddibenzo-p-dioxinsanddibenzofurans(HDDsandHDFs). Thereare4600poten-
tial mixedcongeners. ThebiologicaleffectsofPBDDsandPBDFsaresimilar,ifnotidentical, tothoseofPCDDsandPCDFs.
Bothgroupsofcompoundsinducehepaticarylhydrocarbonhydroxylase(AHHdand (EROD)
inratsandcausewastingandthymicatrophyinrtsandguineapigs.Ibtrabronateddinenz-p-dioxin (TBDD)anddiben-
zofuranCITBDF)arereproductivetoxinsinmiceandproduceskinlesionsintherabbit-earacnegenic test. Thebrominated
compoundsappear tobind tothe samecytosolic receptorsbelieved tomediatethetoxicitiesofthechlorinated analogs.
Whencomparedonamolar-concentrationbasis,thebrominatedcompoundsareequipmenttothechlorinatedanalogs.
TBDDisabsorbedafteroral,dermal, orintratracheal administration inrats,storedintheliverandadiposetissue,and
eliminated inthe fecesthrough biliary excretion. The biological half-livesofthe brominatedcompounds appear to be
somewhat shorterthanthoseofthecorrespondingchlorinatedspecies. Thebrominatedcompounds, liketheirchlorinated
congeners, have the potential tocause dermal, hepatic, andgastrointestinal toxicities inhumans. Further, becausethe
carcinogenicpotentialofthechlorinatedcompoundsinhumanshasbeenestablished,thebrominatedcompoundsshould
beconsidered humancarcinogens.
Introduction
Relatively little isknownabouttheenvironmentalandtoxico-
logic significance ofpolybrominateddibenzo-p-dioxins anddi-
benzofurans (PBDDs and PBDFs). These chemicals haveonly
recently been identified as potential environmental pollutants.
The chlorinated analogs ofthese chemicals havebeenstudied for
years.
Polychlorinated dibenzo-p-dioxins and dibenzofurans
(PCDDs andPCDFs) arerecognized as relatively low-level but
toxicologically significantenvironmental contaminants. These
materials are notmanufactured commercially, but some appear
as impurities in certain products such as herbicides and
fungicides. In addition, significant amounts ofthese important
chemicals are produced in thermal reactions, such as those in
municipal and industrial wasteincineration, accidental fires, and
the burning of automotive fuels that contain chlorinated
additives. Infact, the generation ofPCDDs and PCDFs is con-
sidered likely wheneverorganic materials and a suitable chlo-
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rine sourcearecombusted underoxygendeficientconditions.
Theexperimental andclinical toxicology ofthePCDDs and
PCDFs have been extensively studied and well documented;
therefore, theywill notbeextensivelyreviewedinthispaper. The
mostpotentPCDDsandPCDFsarethe2,3,7,8-chlorocongeners,
butallareconsideredtopossesssignificanttoxicologicpotential
(1-3). Human exposures to PCDDs and PCDFs have been
associated withdermal, hepatic, gastrointestinal, andpossibly
neurologic toxicity. Also, 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD)hasbeenshowntobeapotentcarcinogeninlaboratory
rodents, andFingerhutetal. (4)havereportedanassociationbe-
tweenhighcumulativedosesandexcesscancermortalityamong
occupationallyexposedhumans. PCDDsandPCDFshavealso
been shown to produce immunologic, reproductive, and
developmental toxicities in laboratory animals.
There are only limited quantitative data regarding the en-
vironmentaloccurrenceofPBDDsandPBDFs,anditisimpossi-
bleatthistimetoprojectthemagnitudeofhealthhazard, ifany,
that may attend the accidental and/or incidental production of
these compounds. However, their structural similarities to the
PCDDsandPCDFsmakethemlogicalsubjectsforenvironmen-
talandtoxicologicinvestigation. Thepurposeofthiscommuni-
cationistopresentapreliminary reviewoftheliteratureconcern-
ing thehumanhealth hazardpotential ofPBDDsandPBDFs.MENNEARANDLEE
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FIGURE 1. Structural formulas of unsubstituted dibenzo-p-dioxin and
dibenzofuran.
Formation, Occurrence, and Stability
of PBDDs and PBDFs
It has been recognized that the environmental presence of
halogens such as bromine, and to a lesser extent iodine and
fluorine, hasthepotential ofgiving rise to the formationofad-
ditional polyhalogenated dibenzo-p-dioxinsanddibenzofurans
(PHDDsandPHDFs)underthe sameconditions asPCDDand
PCDF production (5). The structural formulas ofunsubstituted
dibenzo-p-dioxinanddibenzofuranandthenumberingofthe car-
bon atoms are shown in Figure 1. Thehalogenatedcompounds
discussed inthisreviewcontainbromine(orchlorine) attheposi-
tions indicated in their names.
PBDDs and PBDFs can be produced by the pyrolysis of a
variety ofbrominated flame retardantchemicals (6-17) and/or
flame-retarded polymericmaterials. Underconditions in which
a source ofchlorine is also available, bromo/chloro dibenzo-p-
dioxins and furans are most likely produced. Because
chlorinated derivatives arepreferably formed during pyrolysis,
fullybrominatedcompounds willonlyrarelybeproduced, and
themixedcompounds willpredominate (5). Inthisregard, while
there are only 210 possible congeners containing a single
halogen, a total of 4600 discrete bromo, chloro, and mixed
halogen derivatives are possible.
Halogenated dibenzo-p-dioxins and dibenzofurans are also
produced during the incineration of organic materials in the
presence ofhalogens. The specific halogenated congeners and
amounts formeddepend onthereactivity oftheprecursors, pro-
ductstability, andtheBr/Cl ratios. Whileassuming otherfactors
to be equal, Buser (5) computed the probable distribution of
HDDs and HDFs formed during organic incineration in the
presence ofvarious Br/Cl ratios. When Br/Cl = 1, the mixed
halogenatedderivatives areexpectedtopredominate, withonly
small amounts of products containing a single halogen (i.e.,
eitherbromine orchlorine) being formed. In thepresence ofa
10-fold excess of chlorine relative to bromine, the fully
chlorinated compounds are likely to predominate, but mixed
derivatives will still be present in small amounts.
Thesepredictionsareofpractical importbecauseBr/Cl ratios
almostcertainlyvaryfromsitetosite. Forexample,inmunicipal
incinerators, thesourcesofchlorinenormally farexceedsources
ofbromine. Undertheseconditions, polychlorinatedderivatives
would be expected to predominate. The widespread use of
brominated flame retardants in commercial products such as
carpets, textiles, andplasticsandtheirinevitabledisposal, atleast
inpartby incineration, affordapotentially significant sourceof
bromineforthegenerationofbromoandbromo/chlorodibenzo-
p-dioxins anddibenzofurans.
Theresults ofanalysesofenvironmental samples areconsis-
tent with Buser's prediction of the production of mixed
derivatives. The analysis of ash from municipal incinerators
(18-21) aswellasautomobileexhausts (5,7,22) hasrevealedthe
presence of primarily bromo/chloro dibenzo-p-dioxins and
dibenzofurans.
Neupert et al. (23) examined the stability of PBDDs and
PBDFsunderlaboratoryconditions. Solutionsof2,3,7,8-TBDD
or TBDF in toluene were exposed to fluorescent light, at
laboratory temperature, 24 hr/day forup to 6 days. Both com-
pounds underwent degradation, with the furan appearing to
degradesomewhatfasterthanthedioxin. After 15 days, the con-
centrations ofthe solutions had declined to less than 35% of
original. Themajordecompositionproductsweredebrominated
compounds containing from one to three bromine atoms.
Samples of penta-, hexa-, and octa-BDDs and BDFs were
similarly studied, andtherateofdegradation wasdirectly pro-
portional to the degreeofbromination.
Buser(24)comparedthephotolyticdecompositionofbromo
andbromo/chlorodibenzo-p-dioxinsanddibenzofurans tothat
ofthecorrespondingpolychlorocompounds. Whendissolvedin
toluene, both the polybromo and bromo/chloro compounds
underwentdecomposition morerapidlythanthecorresponding
polychloroderivatives. Theseresults suggestthatthebrominated
compoundsmaybe lesspersistentthanthechloroderivatives.
Itshouldbenoted, however,thatenvironmentalPBDD/Fsmay
be less susceptible to photodegradation than are laboratory
samples. Studying the degradation ofPCDDs and PCDFs ad-
sorbed to fly ash, Koester and Hites (25) found no significant
photodegradation, although the compounds are susceptible to
photodegradation when dissolved in various organic solvents.
These results may suggestthatphotodegradation may notbe a
significantmechanismfortheremoval ofthechlorinated com-
poundsfromtheenvironmentandmayalsobelesseffectivethan
anticipatedinremovingthebromoandbromo/chloroderivatives.
Similarexperimentswiththebrominatedcompoundshaveyetto
be conducted.
Toxicity in Experimental Animals
Single-dose Studies
Moore et al. (26) reported on the comparative toxicities of
2,3,7,8-TCDF and TBDFadministeredby gastricintubation to
maleHartleyguineapigs. TBDF wasdissolved incornoil and
administeredinsingledosesof0,0.47, 1.58,4.74, or 15.81,,g/kg.
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Thesedoses ofthebromocongenerarethemolarequivalentsof
0,0.3, 1.0, 3.0. or 10jg/kgofthechlorinatedcongenerTCDF. Ac-
tualdosesofTCDFadministeredinthisstudywere, 1.0,5.0, 10,
or 15jig/kg. Animalswereobserveduntildeathorfor30daysafter
dosing. Gross signsoftoxicity producedbythetwoHDFswere
similarandincludeddecreasedbodyweightgainsafterthelower
doses(1.0jig/kgforTCDFand4.74jig/kgforTBDF)andprompt
body weightlossafterthehigherdoses (10jg/kgforTCDFand
15.8 jg/kg forTBDF). Theminimum lethal doseofTBDF may
have been somewhat lower than that ofTCDF (4.74 jig/kg for
TBDF versus 10 jig/kg for TCDF), but the number of doses
studiedandanimalgroupsizesweretoosmalltoallowmeaningful
comparisons.
TCDDisknowntoproduceaspectrumoftoxicologicaleffects
in laboratory animals, with markedquantitative differences be-
tween species. Poland and Knutson (1) reviewed the toxicity of
TCDD and relatedaromatichydrocarbonsandnotedthatthetox-
icsyndromeproduced inlaboratory animalsbythesecompounds
frequently includes wasting, lymphoid involution, hepatotoxici-
ty, epidermal changes, gastric lesions, and urinary tract
hyperplasia. Mason et al. (27) demonstrated that a series of
polybrominated and bromo/chloro dibenzo-p-dioxins produced
body weight loss and thymic atrophy in immature maleWistar
rats. The compounds studied (1,3,7,8-TBDD; 2,3,7,8-TBDD;
1,2,3,7,8-PeBDD; 1,2,4,7,8-PeBDD; 2,3-dibromo-7,8-di-CDD;
and2-bromo-3,7,8-tri-CDD) wereadministered IP(doseranges
studied were not specified), and animals were observed for 14
days. Each ofthe compounds reducedbody weight and caused
thymicatrophy. TheED50forbodyweightlossrangedfrom 1.24
x 10-8M for 2,3-dibromo-7,8-di-CDD to 2.52 x 10-4M for
1,3,7,8-TBDD. Theorderandmagnitudeofpotency fortheinduc-
tion ofthymic atrophy were similar.
LikethemoreintensivelystudiedCDDsandCDFs,thebromi-
nated derivatives are also potent inducers of microsomal
monooxygenaseactivity. Thebromoandbromo/chlorodibenzo-
p-dioxinsarecapableofinducinghepatic, arylhydrocarbonhy-
droxylase (AHH) and ethoxyresorufin-o-deethylase (EROD)
either in vitro (rat hepatoma H-4-11 E cells) or in vivo (rats).
Mason etal. (27) comparedthe relative abilities ofTCDD and
TBDD to bind to rat liver cytosolic receptors (hydroxylapatite
receptorbindingassay)andtoinduceAHHandERODinvitro.
The affinities ofthe compounds for receptor binding sites ap-
pearedtobeequivalent, andthechlorinederivativeappeared to
besomewhatmorepotentasaninducerofAHHandEROD. The
resultsofinvivoexperimentsdemonstratedenzymeinductionby
aseriesofbromoandmixeddibenzo-p-dioxins. Nagaoetal. (28)
andSchulz-Schalgeetal.(29)havereportedsimilar viWvohepatic
enzyme-inducing potencies of chlorinated and brominated
compounds.
Thereappears tobe ahighdegreeofcorrelationbetweenthe
ability ofPHDDs and PHDFs to induce AHH activity in vitro
andtoproduceinvivotoxicity. Safeetal. (30)studiedaseriesof
27PCDD,PCDF,PBDD,andPCBcongenersandreportedhigh
correlationcoefficients(r>0.9)betweeninvitroenzymeinduc-
tionandtheED50foreitherbodyweightlossorthymicatrophy
inrats. Thespecificcongeners studiedanddosestestedwerenot
specified inthepublication.
Repeated-Dose Studies
Hardy et al. (31) administered TBDF to male and female
Sprague-Dawley rats 5 days/week for 4 weeks. TBDF was ad-
ministered as a corn oil gavage at 0, 1, 10, 50, 150, or 500
jig/kg/day (0.002to 1.03jimole/kg/day). Allanimalsthatreceived
50jig/kg/day orless survived for thescheduleddurationofthe
study. All animals administered 500 jg/kg/day died or were
sacrificed in extremis; 70% of the animals receiving 150
jig/kg/day died. Animalsdosed with 50jg/kg/day or more ex-
hibited decreased body weight gains. Mean thymus weight
(relative to body weight) was decreased in males by 150
jig/kg/day and in femalesby 10 and 50jig/kg/day. Male kidney
andtestes-to-body-weightratios weresignificantlyincreased by
the 50 and 150jig/kg/daydoses. Liver, kidney, spleen, adrenal
gland, heart, andthymusfromanimals inthecontrol, and 1, 10,
and 50 jig/kg/day groups were examined microscopically.
Hepaticlesionswerecharacterizedaspanlobularhypertrophyof
thehepatocytes withassociatedpanlobularhepatocyte vacuola-
tion and focal necrosis.
LUserandIvens(32)conducteda 13-weekstudyofthetoxicity,
storage, and elimination ofTBDD in male and female Wistar
rats. Animals were administered TBDD by daily gavage in
arachis oil (0.01, 0.1, 1.0, 3.0 or 10 jig/kg; 0.00002 to 0.02
jimole/kg) for91 days. Thelowestlethaldosewas3.0jig/kg for
bothsexes, andallratsinthe 10jig/kggroupdiedorwerekilled
in extremis before the scheduled termination ofthe study. The
authors statedthatanimalsdosedwitheither0.01 or0.1jIg/kgex-
hibitednotreatment-related signsoftoxicity; however,0.1 jig/kg
(orhigher)produceddecreases inserumthyroxininboth sexes.
Therewasalsoanincrease intriiodothyronine inanimalsdosed
with 1 or3jig/kg. Themajoreffectsnotedinthe3and 10jig/kg
groups included decreased body weight gain, poor general
health, icterus, and, after 12 weeks, increased plasma alkaline
phosphatase, alanine aminotransferase, and aspartate
aminotransferase inthe 3jg/kg groupanimals that survived to
the scheduledtermination ofthestudy.
Toxic Effects in Humans
Reports describing toxic effects in humans attributable to
PBDDs or PBDFs were not found. However, given the
similaritiesbetweenthePCDDs, PCDFs, PBDDs, andPBDFs,
it is reasonable topredictthatthebrominated compounds will
producethesamespectrumofeffects inhumansasproducedby
thechlorinated compounds.
Despite a wide variety of toxicological manifestations ex-
hibitedbylaboratoryanimalsafterexposuretothePCDDsand
PCDFs, toxicologicaleffectsinhumans (otherthantheproduc-
tionofchloracne) arenotwelldocumented(1-3). Severalreports
suggestpossible immunosuppression in humans, but these ef-
fectshavenotbeenunequivocally proven[reviewedbyLorenzen
andOkey (33)].
A common element found in nearly all pathological lesions
associated with PCDDs and PCDFs is the presence of the
geneticallysegregatedAhreceptor, andthecurrentconsensus is
thattoxicityofeitherclassofchemicalsismediatedthroughthis
receptor. Lorenzen and Okey (33) have demonstrated the
presence ofthis receptor in cells from the human tonsil. The
receptor was found to bind T1CDD and to be transformed to a
nuclear binding form. Further studies on the interactions of
polyhalogenatedcompoundswiththehumanAhreceptormight
provideuseful insightsintothehumantoxicologicalpotentialof
thebrominated compounds.
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Developmental Toxicity in
Experimental Animals
PBDDsandPBDFs are potentdevelopmental toxins inmice.
Theevidenceindicatesthatcompared tochlorinatedanalogs, re-
placementofchlorinewithbromine may reduce potency some-
what, butdoes notappeartoalterthemechanismthroughwhich
this classofchemicals exerts itsdevelopmental effects (34).
TCDD is a potentdevelopmental toxin in mice, causing cleft
palate and hydronephrosis at dose levels that produce no overt
maternal orfetaltoxicity(35). Birnbaumetal. (34)studiedtheef-
fectofsubstitutingbromineforchlorineintheTCDDmolecule
on teratogenic potency. In addition to studying thebrominated
analogofTCDD, theseworkersalsoassessedthedevelopmental
effectsofTBDF, 1,2,3,7,8-penta-BDF (lPeBDF), and 2,3,4,7,8-
penta-BDF (4PeBDF). Corn-oil gavage doses administered to
pregnant C57BL/6N mice on gestation day 10 ranged from 0 to
192 Ag/kg (up to0.38jtmole/kg) forTBDDand from0 to4,000
jg/kg forTBDF, lPeBDF, and4PeBDF. Alldosesofeach com-
pound significantly increasedliverweights inthedamsbutpro-
duced nootherevidenceofmaternaltoxicity. TBDDandTBDF
causeddose-related increases infetalweights, and500jg/kg or
moreofTBDF significantly increasedembryo/fetal mortality.
The induction of hydronephrosis was the most sensitive
measure ofdevelopmental toxicity. The incidence was increas-
ed by each compound, and ED50 doses were estimated to be
TBDD, 9 jg/kg; TBDF, 12 pg/kg; lPeBDF, 340 pg/kg; and
4PeBDF, 4347 tg/kg. Theauthors estimatedthattheED50dose
for TCDD to produce hydronephrosis was 4.0 ,g/kg. Thus,
TBDD, the most potent inducer of hydronephrosis of the
brominated congeners tested, was estimated toberoughly one-
half as potent as TCDD in this regard. When molar doses are
compared, TBDD and TCDD were approximately equipotent.
All ofthe PBDDs and PBDFs alsocausedsignificant increases
in the incidence of cleft palate. Estimated ED50 values were:
TCDD, 15.3 Aglkg; TBDD, 65.1 jig/kg; TBDF, 153.5 Ag/kg;
lPeBDF, 4,087.6jtg/kg; and4PeBDF, 3024.3jg/kg. Probitplots
ofthecleftpalate incidences revealed acommonslope, whichthe
authors interpreted to suggestthatthecompounds may produce
their effects through the same mechanism.
Nagao etal. (36)comparedthecleff-palate-inducing effectsof
TBDD in NMR1 mice. Animals were dosed with from S to 90
jtg/kg ofeither TBDD or TCDD on day 9 of pregnancy. Both
compoundsproducedonlyminimalevidenceofmaternaltoxicity
(increased liver-to-body-weight ratiosatalldoselevels). Neither
TBDD nor TCDD affected fetal weights or numbers ofviable
fetuses per litter: There were, however, clear dose-related in-
creases intheincidencesofcleftpalate inpupswhosedamshad
beendosedwitheithercompound. TheED50valueforTBDDwas
estimatedtobe61.7 tg/kgascomparedto65.1tig/kgreportedby
Birnbaum(34).TheEDj0ofTCDDtoinducecleftpalatewascom-
putedtobe24jtg/kg. Nostudiesofotherreproductiveeffectsof
PBDDsorPBDFsinlaboratoryanimalsorhumanswerereported.
Mutagenicityand Other Indications
of Genotoxicity
The International Agency for Research on Cancer (37) re-
viewed the genotoxic potential ofTCDD and reported that the
compound did not produce dominant lethal mutations,
chromosomal aberrations, micronuclei, orsisterchromatid ex-
changes in rodents treated in vivo. It was mutagenic to mouse
lymphomacellsbutdidnotinduceunscheduled DNA synthesis
inrathepatocytes in vitro. TCDDwasnotmutagenictobacteria.
No reports relating directly to the genotoxicity ofPBDDs or
PBDFswerefound. Sincethein vivoandin vitrobiological ac-
tionsofTCDDandTBDDappeartobesimilar, informationon
thegenotoxicityofTCDDdoesnotsuggestanimminentgenotox-
ic threatfromthebrominated compound. Studiesonthebromo
and bromo/chloro compounds are clearly indicated.
Carcinogenicity
Experimental orepidemiological studiesofthecarcinogenic
potentialofthePBDDsandPBDFshavenotbeenreported, and
weare unaware ofstudies in progress. 2,3,7,8-TCDD is clearly
carcinogenicinlaboratoryanimals (37), andthereisagrowing
body ofevidenceindicating thatitisalsocarcinogenicinhumans
(4). Forthese reasons itisprudenttoassumethat2,3,7,8-TBDD
is probably carcinogenic also.
Absorption, Excretion, Distribution
and Metabolism
Inexperiments inwhichTBDDhasbeencomparedtoTCDD,
the absorption, elimination, and distribution ofthe two com-
pounds appeartobe similar. Althoughnotstudied simultaneous-
ly, the elimination ofTBDD and TCDD appears to be similar
also.
Absorption and Elimination
The studies that have been reported on TBDD to date show
that, inrats, thecompoundisabsorbedafteroral, dermal, orin-
tratrachealadministration, andtheprimary routeofelimination
is the feces, with biliary excretion appearing to be the major
source ofcompound.
Diliberto et al. (38) studied the absorption and excretion of
orally administered [3H]TBDD inmaleF344 rats. Doses studied
included 0.001, 0.01, 0.1. or 0.5 Amole/kg. These doses are
equivalentto0.5 to250,g/kg. Themajor routeofexcretion was
thefeces. Seventy-twohrafteradministration, fecalexcretionac-
countedfor30-80% oftheadministereddose. Urinary excretion
wasnotdescribed. Attheterminationoftheexperiment, thema-
jority ofthebody burden was located in liverand fat. Concen-
trations in these tissues for animals exposed to the two lower
doses were directly related to size ofthe dose. Higher doses,
however, wereassociatedwithadecreasedpercentageofthead-
ministereddoseremaining intissues. Thedose-relatedincrease
infecalexcretionanddecreaseinrelativetissueresiduesathigher
doses suggest that, at the doses studied, absorption ofTBDD
fromthegastrointestinal tract is nonlinear.
Diliberto et al. (39) reported absorption and excretion data
aftertheadministrationof[3H]TBDD to male F344 rats by in-
tratracheal instillation. Three days after the instillation (1.0
nmole/kgin250 Lethanol: Emulphor: water),22% ofthead-
ministered radioactivity wasfoundinadiposetissueand 18% was
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inthe liver. Themajor routeofexcretionwasthefeces, whichac-
counted for37% oftheadministered radioactivitywithin72hr.
Jackson etal. (40) reported thatapproximately 12% ofader-
mally applieddoseof[3H]TBDD (1.0nmole/kgdissolved in60
uLofacetone) wasabsorbedduring 72 hr. Approximately 13%
ofthe radioactivity remained in the application site, and major
tissuedepotswere foundtobeliverandadiposetissue. Theliver
to adipose tissue concentration ratio was 3:2. Elimination (on-
ly 17% ofthe absorbed dose) was primarily via the feces. The
authors stated that at equimolar doses, only 30-40% as much
TBDD was absorbed through rat skin as was TCDD (40).
Kedderis etal. (41,42)estimatedthatthewhole/bodyhalf-life
ofTBDD was 2-3 weeks in F344 rats after the IV injection of
0.001 or 0.1 pmole/kg (0.5 or 50 jig/kg). By 56 days after ad-
ministration, 50% ofthelowdoseand70% ofthehighdosehad
been excreted inthe feces. Urinary excretionaccountedfor4.5%
oftheadministered lowdoseand7.6% oftheadministered high
doseduring the sameperiod. Kedderisetal. (42) alsocompared
the biliary excretion of IV-administered [3H]TBDD and
[3H]TCDDbymaleF344rats. Duringtheinitial 8hrafterthead-
ministration ofeither0.001 or0.1 pmole/kg ofTBDD, 6-8% of
the administered radioactivity was excreted inthebile. Similar
results were obtained when equimolar doses of TCDD were
administered.
Distribution
Absorbed TBDD is quickly distributed from the blood to
skeletal muscle, skin, liver, and adipose tissue in rats. Highest
tissue concentrations are achieved in the liver, with a gradual
redistribution to adipose tissue. The compound is mostpersis-
tent inadiposetissueandskin, withhalf-livesofapproximately
58 days in both tissues.
Single-DoseStudies. Kedderis etal. (43) studiedthedisposi-
tionof[3H]TBDD inmaleF344ratsfor56daysfollowingthein-
travenous injection ofeither 0.001 or 0.1 umole/kg (0.5 or 50
Aglkg). Afterthelowdose, TBDD was rapidlyclearedfromthe
blood, with levelsdecliningtolessthan2% oftheadministered
dose within 1 day. Hepatic radioactivity peaked at 7 hr then
declined (half-life, 17days). Adiposetissueconcentrations rose
through day 14, then slowly declined (half-life, 58 days). Ap-
proximately 10% oftheadministeredradioactivity wasfound in
the skin at 7 hr and a biphasic elimination from this tissue
resulted in a long half-life similar to that ofadipose tissue (58
days). Concentrations inmusclegenerallyparalleled thoseinthe
blood, peaking early anddeclining rapidly.
Althoughthehighdose(0.1 mole/kg) was 100times greater
than the low-dose, liverconcentrations were almost 700times
greaterinthehigh-thaninthelow-dosegroupsat56days. These
results indicate dose-relateddifferences indeposition. Inaddi-
tion, the relationship betweenradioactivity in liverandadipose
tissueexhibitedbothtime-anddose-dependentbehavior. Atthe
low dose, liver-to-adipose-tissue concentration ratios declined
fromahighof30onday I toapproximately 1 onday 14. Byday
56, adiposetissuecontainedabout6-foldmoreradioactivitythan
liver. Theseresults suggestacontinued redistributionofTBDD
from livertoadiposetissue. Bywayofcontrast, 56daysafter0.1
i mole/kg, concentrations ofradioactivity intheliverwerestill
two to threetimes greater than those inadipose tissue.
Repeated-Dose Studies. Ivens et al. (44) administered daily
dosesof0.01, 0.1, 1.0, 3.0, or 10.0pg/kg (0.00002, 0.0002, 0.002,
0.006 or0.02 gmole/kg) ofTBDD as a daily arachis oil gavage
tomaleWistarratsfor91 days. Concentrations ofTBDD inliver
andadiposetissueweredeterminedatseveralintervalsduringthe
dosingperiodandat 100, 121, and 184daysaftercessationofad-
ministration(recoveryperiod). TissueconcentrationsofTBDD
increased in dose- and time-related fashions throughout the
periodofadministration. LiverlevelsofTBDDdeclinedprompt-
lyduringtherecoveryphase. Within93days, hepaticlevelswere
reducedby98% ofthelevelsproducedby91 consecutivedaysof
dosingwith 1 pg/kg. Adiposetissuelevelsdeclinedmoreslow-
ly, with no significant decrease during the initial week of
recovery and an 86% decline after 93 days ofrecovery. These
resultsaresuggestiveofmultiphasiceliminationofTBDDfrom
the liver andadipose tissue. The authors noted thattissue con-
centrations achievedafterthedaily administration of 1.0pg/kg
ofTBDD for91 dayswereapproximately halfthosereportedby
Kociba et al. (45) after the administration ofthe same dose of
TCDD5 daysaweekfor 13weeks. Ivensetal. (44) suggestedthat
thisobservationmayindicatethatthehalf-lifeofTBDDisshorter
thanthatofTCDD.
Metabolism
Although little information on the biotransformation ofthe
PBDDsandPBDFswasfound, itisclearthatTBDDundergoes
metabolism in F344 rats. Kedderis etal. (42, 43) reported that
80-90% ofbiliary and fecal radioactivity excreted by rats ad-
ministered [3H]TBDDIVwasintheformofTBDDmetabolites.
No parent compound was found in the bile, but 10-20% ofthe
radioactivity found in thefeces on days 1 to 3 was TBDD. The
natureoftheexcretedradioactivity wasexaminedby HPLCand
foundtoelutebeforeknownTBDD, indicatingincreasedpolarity
relativetotheparentcompound. Themetaboliteswerenotiden-
tified. HPLCanalysisof3Hextractedfromlivershowedthatall
radioactivity presentelutedwiththeparentTBDD. Pretreatment
withTBDD(0.1 tmole/kgbygavage3daysbeforeIV injection
of0.001 zmole/kg [3H]TBDD) increased hepatic uptake ofthe
radiolabelbuthadnoeffectonbiliaryexcretion. Similarresults
were obtained when rats were dosed with equimolar doses of
TCDD.
Bioaccumulation/Bioconcentration
Studies dealing directly with the bioaccumulation and
bioconcentration ofPBDDsand PBDFs are limited. However,
the results of three reports suggest that the brominated com-
pounds may exhibitlessbioaccumulationandbioconcentration
thantheirchlorine analogs. Neupertet al. (23) reported that a
seriesofPBDDsandPBDFs werelabiletoartificiallight. Under
similar conditions the chlorinated TCDD and TCDF did not
degrade. Ivensetal. (44)reportedhepaticandadiposetissueac-
cumulationofTBDDinratsduringsubchronicadministration.
Although both tissues accumulated the compound during ad-
ministration, concentrations in both began to decline shortly
aftercessationofdosing. The rateofdeclineofthebrominated
compoundfromthesetissuesisfasterthanthatofTCDD. These
results suggestthatthebiologicalhalf-lifeofTBDD islikely to
belessthanthatofTCDD. Kedderisetal. (43)estimatedtheter-
minal whole-body half-life ofTBDDin rats to be 18 days after
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a single high or low IV dose. This is similar to results reported
by Rozmanetal. (46) forTCDDbutsomewhatshorterthanthe
31-day half-life estimatedforTCDD intheratby Roseetal. (47).
Obviously, unequivocal statements regarding the bioac-
cumulation andconcentration ofthePBDDsandPBDFscannot
be made. It is likely that the number ofbromine atoms on the
molecules influences biological half-life. Ifthis isthecase, the
bioaccumulation and concentration of the mixed halogen
compounds will probably be different from that ofeither the
completely brominated or chlorinated derivatives. Studies of
bioaccumulation ofPBDDs and PBDFs are required.
Ecological Effects
Effects onOrganisms
Studies addressing thepotential effectsofPBDDs and PBDFs
on environmental organisms were not found. Given the
similarities betweenthechlorinatedandbrominatedderivatives,
however, it is reasonable to usedataonthePCDDsandPCDFs
to make an initial extrapolation to the PBDDs and PBDFs.
Mehrle et al. (48) tested TCDD and TCDF in rainbow trout
(Salmo gardneri). Fish were exposed to the chemicals for 28
days, then transferred to uncontaminated water for a 28-day
depuration period. The no-observable-effect concentration
(NOEC) forTCDD was found tobelessthan0.38 X 10I- tg/L
(the lowest concentration tested). Deaths occurredthroughout
theentiredepurationphase, evenwiththelowestconcentration.
Ina similarexperimentwith TCDF, theNOEC forsurvival was
17.9 x 10-4 tg/L and the NOEC for growth was 4.1 x 10-4
AgIL. Based onexperiments conducted in mammalian systems
(34,44), onewouldexpectpolybrominated congeners tobeap-
proximately halfastoxiconamicrogramperliterbasis (essen-
tially equipotent on a molarbasis).
Tissue Residues
Kuehletal. (49)analyzedchemicalresidues inAtlanticOcean
dolphins that had died during the 1987-1988 massmortality. A
total of21 animals (14bottlenose, 3whitesided, and4common)
were surveyed. In addition to a variety ofpesticide residues,
several PCDFs and 1,2,3,4,6,7,8-HpCDD were found. TCDD
was notdetected in theblubberofanyanimals, buttheauthors
statedthismightbeareflectionofarelatively insensitivemethod
ofanalysis (15 pg/g tissue). Tissue samples from threeanimals
werealsoevaluated forthepresenceofunknownchemical con-
taminants. In addition to contaminants later identified as
polybrominated biphenyls (PBBs, 17 ng/g lipid) and
polybrominated diphenylethers (200ng/glipid), these authors
reported the presence of several other polybrominated con-
taminants. One compound, with a molecular weight of 650
daltons, appears to contain both bromine and chlorine atoms.
Thismolecularweightisnotinconsistent withthepresenceofa
polybrominated/chlorinated dibenzo-p-dioxin. Efforts tofully
characterizetheunidentifiedcompoundsarecurrentlyunderway.
Mechanism ofToxicity
Based on a limited amount of testing, it appears that the
PBDDs andPBDFsproducetoxicty inlaboratory animals that
is qualitatively similar to that produced by the PCDDs and
PCDFs. When in vivo exposures andin vitro concentrations of
TCDDandTBDDareexpressedintermsofmicrograms, TCDD
appearstobeapproximately twiceaspotentasTBDD. However,
when doses and concentrations are expressed on the more ap-
propriate molar basis, the two compounds appear to be
equipotent.
Becauseofthe similarchemical behaviorofchlorinated and
brominatedderivatives, itseems possiblethatthetwogroupsof
chemicals may actthroughthe samecytosolic receptor-mediated
mechanism. Differences in potency and duration ofaction (if
theyexist) mightbe reflections ofdifferentratesofmetabolism
ordifferentaffinities forbinding to the cytosolic receptor.
Receptor-Mediated Toxicity
There is compelling evidence that the toxic responses to
TCDDandrelated HDDsandHDFs(including thebrominated
compounds) are mediated through interactions with cytosolic
receptor(s), assummarizedattheBanburyConferenceonDiox-
in (50). Ithas beenproposed thatthetoxicologic actions ofthe
HDDsandHDFsproceedthroughaninitialbindingofthetoxi-
cant to a cytosolic receptor protein. Given the chemical
similarities between chlorine and bromine, it is reasonable to
suspectthatboth bromineand chlorine congeners will interact
withthe same receptors. However, chlorineand bromine bond
strengths as well asthe relative sizesofthehalogenatomsdiffer.
These factors may influence receptorbinding affinities as well
astherelativesusceptibilities ofthemolecules toenzymatic at-
tack and biotransformation. Under these circumstances one
would expect qualitatively similar effects to be produced by
chlorinated andbrominated compounds, with any quantitative
differences being attributable to the nature of the halogen
substituent.
Althoughnotaffordingunequivocalproof, theresultsofsome
recent studiesonthebrominated derivatives areconsistentwith
thesuggestionthatthebrominated andchlorinatedcompounds
interact with the same receptors. Both brominated and
chlorinatedderivativesinducehepaticAHHandEROD, withthe
chlorinatedderivativesbeingmorepotent(6,27,28,30,51). Most
recently, Birnbaum et al. (34) found that the teratogenic (cleft
palate)dose-responsecurvesforPBDDsandPBDFsinmiceare
paralleltothoseofTCDD. Theauthorsnotedthatparalleldose-
response curves may be suggestive of similar mechanisms of
action.
Toxicity Equivalency Factor/TCDD
Equivalent
The enormous number of polybrominated and mixed
(brominated/chlorinated) dibenzo-p-dioxins anddibenzofurans
makes the investigation ofthe toxicologic potential of even a
small percentage of these compounds unrealistic. A similar
dilemmaexistsinthecaseofthePCDDs and PCDFs. The tox-
icity equivalency factor(TEF) concept(52,53), whichdepends
onastrongstructure-activity relationshipbetweenthecongeners
andtheirability toelicitabiological/toxic responseinvariousin
vitro and in vivo test systems allows theassignment ofpotency
factorsforindividualmembersofachemicalgroup. Thepotency
factorexpressesthetoxicityofaspecificcongenerrelativetothat
ofa well-studied standard. In the case ofPCDDs/PCDFs, the
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standard chemical isTCDD. Inestimatingthetoxicologic poten-
tial ofanenvironmental sample or acomplexmixture, the con-
centration ofeach congener present multiplied by itsequivalency
factor gives the concentration ofthe congener in terms ofthe
TCDD equivalent. Thepotentialeffectofthesample ormixture
is expressed by the sum ofthe TCDD equivalent, as ifit were
concentration of TCDD itself. Safe (3) and Safe et al. (31)
reviewed several classesofhalogenatedaromaticsand suggested
that the TEFs established for the PCDDs and PCDFs can be
similarly used for the bromo and bromo/chloro dibenzo-p-
dioxins and dibenzofurans.
Comparative Potencies ofPCDDs and PBDDs
Nagao etal. (28) compared theabilitiesofTCDDandTBDD
to induce hepatic EROD in rats. The compounds were ad-
ministered in single SC doses (TBDD, 0.006 - 6.0 nmole/kg;
TCDD, 0.003 - 10nmole/kg). Bothcompounds induced EROD,
with the magnitudesofinductionandthetime courses ofeffects
being identical for the two compounds. On a microgram per
kilogram basis, TCDD appeared to be approximately twice as
potent as TBDD, but on a molar basis, the compounds are
equipotent for the induction of EROD in female Wistar rats.
Undertheconditions ofthisexperiment, theresults indicate that
the TCDD equivalency ofTBDD, when expressed on a molar
basis, is 1.0. Whenexpressed on amicrogram perkilogrambasis,
it is 0.5.
Correlations between in VitroEnzyme
Induction Potency and the Production ofWeight
Loss andThymic Atrophy
Safe et al. (30) assessed the abilities of a total of27 PCDD,
PCDF, PCB, and PBDD congeners toinduceAHH, thendeter-
mined their potencies to induce body weight loss and thymic
atrophy. The authors reported excellent correlations between
ECso concentrations for enzyme induction and ED-o doses for
eitherbodyweightlossorthymicatrophy (r>0.9). Theydidnot,
however, presentindividualdataforthebrominatedcompounds
that were studied. Despitethis, the results indicatethatdirectand
consistent relationships exist between the potencies of the
chemicals to produce these effects. Such relationships are re-
quired for the determination ofmeaningful toxic equivalency
factors.
Correlations between in VivoEnzyme
Induction and the Production ofWeight Loss
andThymic Atrophy
Mason et al. (27) compared the abilities of bromo and
bromochlorodibenzo-p-dioxins toinduceAHHandERODand
to causebodyweight lossandthymic atrophy in immature male
Wistar rats. Rats were administered (unspecified) doses ofthe
congeners-bytheIProute 14daysbeforetheassay ofhepatic en-
zyme activity and the determination of thymus (and body)
weights. The molar ED-o values for body weight loss, thymic
atrophy, andAHHandEROD induction werecalculated. Com-
putationsofcorrelation coefficients revealedclearrelationships
between the magnitudes of biochemical changes and the tox-
icologic effects: AHH induction versus body weight loss,
r20.97; AHH induction versus thymic atrophy, r20.97; EROD
induction versus body weight loss, r>0.99; EROD induction
versusthymicatrophy, r>0.98. Theresultsoftheseexperiments
suggestthatdetermining acongener's potency forinducingeither
AHH or EROD can predict its potency to elicit either body
weight loss orthymic atrophy in rats.
Comparison ofCytosolic Binding Affinities
andHepatic EnzymeInduction
Mason etal. (27) studiedthecorrelations betweentherelative
binding affinities ofPCDDsandPBDDsfor rathepaticcytosolic
receptorandintheabilitiesofthecompounds toinducehepatic
AHH and EROD activity in rat hepatoma H-4-II E cells in
culture. Calculation of correlation coefficients revealed dif-
ferences in the relative potencies of the compounds in their
abilities tobind tothecytosolic receptorand intheirabilities to
inducehepatic enzymes. Althoughexplanationsforthis lackof
correlation are notimmediatelyobvious, theresults suggestthat
events orfactorsoccurringsubsequenttobinding tothecytosolic
receptor are important with regard to differences between
chemicalsandtheirabilities toelicit aneffectsuch as enzymein-
duction. Theauthorsdidfind, however, thatthebindingaffinities
ofTBDDandTCDDforthecytosolic receptor weresimilar(27),
supporting theideathatthetoxicologicpotenciesofthe two com-
pounds are roughly equivalent on amolarbasis.
Computation ofTXDD Equivalent ofPyrolized,
Brominated FlameRetardants
Zacharewski etal. (6) pyrolyzed a series ofpolybrominated
flame retardants and analyzed thepryolysates forthe presence
ofPBDDsandPBDFs. Thepyrolysates werefoundtocontain a
complex mixture ofPBDD and PBDF congeners. The in vitro
abilities of the pryolysates to induce EROD and AHH in rat
hepatoma H4-ll cells inculture weredeterminedandcompared
totheinductionproducedby TCDD. Althoughconcentrationsof
TCDD and the PBDDs and PBDFs used for the experiments
were notspecified inthe paper, thecomputedED5ovalues were
presented and wereused to determinethe TCDD equivalentof
the pyrolysates. Because this is the only report on this type of
study, itis impossible todetermineeitherthereproducibility or
the accuracy ofthe TCDD equivalents estimates. The data are
summarized in Table 1.
lIsble 1. Summary ofresultsofpyrolysis ofbrominated flame retardants
andcomputationsofTCDDequivalents from theresultsof
in vitroexperiments.
TCDD equivalent, ppm
Pyrolized flame Total PBDDs and
retardant PBDFs, ppm AHH induction EROD induction
Fire Master
300 BA 10,935 174 194
Fire Master
BP-6 2,070 1,400 480
Bromkal
70-5-DE 610,393 2,140 4,680
Bromkal
70-DE 268,477 8,780 6,740
Bromkal
GI 547,700 3,920 5,260
Abbreviations: TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin; PBDD,
polybrominateddibenzo-p-dioxin; PBDF, polybrominateddibenzofuran; AHH,
arylhydrocarbonhydroxylase; EROD, ethoxresorufin-o-deethylase.
271MENNEARANDLEE
Table 2. Summary ofresultsofcomputationsofTCDDequivalents based
on the results ofin vivoexperiments conductedon pyrolysates oftwo
brominated flame retardants (6).
Pyrolyzed flame Total PBDDs and Computed TCDD
retardant PBDFs, ppm Effect equivalent, ppm
Fire Master BP-6 2070 AHH induction 540
EROD induction 520
Body weight loss 760
Thymic atrophy 1680
Bromkal 70-DE 268,477 AHH induction 5200
EROD induction 3860
Body weight loss 6260
Thymic atrophy 8960
Abbreviations: TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin; PBDD, poly-
brominateddibenzo-p-dioxin; PBDF, polybrominateddibenzofuran; AHH, aryl
hydrocarbon hydroxylase; EROD, ethoxresorufin-o-deethylase.
There was reasonably good correlation between the TCDD
equivalents in the two in vitro experiments. In the case ofFire
Master BP-6, there was anearly 3-folddifferenceincomputed
TCDD equivalents, but differences in estimates for the other
pyrolysates ranged from 1.1 (Fire Master 300 BA) to 2.1
(Bromkal 70-5-DE).
Thein vivoeffectsoftwoofthepyrolysatesonenzyme induc-
tion, body weight loss, and thymic atrophy were also deter-
mined, and TCDD equivalents were computed. The ranges of
results depicted in Table 2 show the estimated concentrations
(ppm) ofTCDDthatwouldhaveproduced the sameeffectsthat
were produced by the pyrolysates.
Zacharewski et al. (6) noted that the estimated value ofthe
TCDD equivalent appeared to be dependent, in part, on the
responsethatwasmeasured. Theypointedoutthattheresultsof
each assay could have been influenced by several factors, in-
cludingpharmacokineticsandmetabolismandtheinteractiveef-
fectsofthemixturesofPBDDs. Becauseofthesefactors, itmight
beuseful toexpressin vivoestimatesoftheTCDDequivalentin
terms ofa range ofvalues.
Toxicologic Effects of MajorConcern
ReportsofhumantoxicityassociatedwithexposuretoPBDDs
and PBDFs were not found. In addition, only limited data are
availableconcerningtoxicity inanimal models. Therefore, itis
impossible tomakeunequivocal statementsconcerning the tox-
icologicpotential thatmightbeassociated withhumanexposure
tothesecompounds. ThelimitedanimaldataonthePBDDsand
PBDFsandtheobservedhumantoxicityofPCDDsandPCDFs
allow a suggestion that human health hazards that could be
associated withexposures tothebrominatedanalogsinclude car-
cinogenicity, developmental toxicity, skintoxicity, hepatotoxici-
ty, gastrointestinal disorders, and immunosuppression.
Carcinogenicity
The International Agency for Research on Cancer (37) has
classified2,3,7,8-TCDD asapossiblehumancarcinogen(group
2B). TheAgency cited sufficientevidenceofcarcinogenicity in
animalsandinconclusiveevidenceinhumans. Sincepublication
ofthatpositionin 1987,evidenceofcarcinogeniceffectsofTCDD
inhumanshasbeenaccumulating [see, forexample, Fingerhut
etal. (4)]. Giventhedegreeofsimilarity between thechlorine
andbrominecongeners itislikelythatTBDDalsopossessescar-
cinogenic potential.
Developmental Toxicity
TheadministrationofTBDDandTBDFtopregnantmice, at
dosesthatcausenoevidenceofmaternaltoxicity, producescleft
palate and hydronephrosis in the offspring (34). These
developmental malformations are also caused by TCDD and
TCDF. Although the mechanism(s) through which these
chemicals produce theireffects remains unknown, TCDD has
been showntopotentiatetheteratogenic effectofretinoic acid.
It has been suggested that TCDD modulates embryonic
responses togrowth anddifferentiation factors (54). Although
TBDDhasnotbeenstudiedforaninteractionwithretinoicacid,
asimilarpotentiation wouldbeexpected (L.S. Birnbaum, U.S.
EPA, personal communication).
SkinToxicity
ThemostcommonandpersistenteffectofTCDDexposurein
humans is the production of dermal toxicity [chloracne, skin
hyperpigmentation, and in many victims conjunctivitis and ir-
ritation of mucous membranes (1-3)]. Pinkerton et al. (55)
reported thatboth TBDDandTBDF wereactive in the dermal
rabbit-eartestforacnegenic activity. However, thesecompounds
were approximately 1000 times less potent than TCDD. It ap-
pears, therefore, thatthebrominatedcompoundshavethepoten-
tial to produce skin lesions in humans, although possibly at
higher doses relative to those required for TCDD.
Liver Toxicity
TCDDhasbeenassociatedwithelevatedserumlevelsofcertain
enzymes as well as the excretion of porphoryins and hyper-
cholesteremia. These signs are all suggestive ofliver impair-
ment. BDDs and BDFs are hepatotoxic in laboratory species.
Theseeffects are similarto those produced by polychlorinated
compoundsandincludetheinductionofenzymesandincreased
liver mass. These effects are not necessarily indicative ofthe
ability ofthecompounds toproducehepatotoxicity inhumans,
but they do suggest thatthe liver is apotential target organ.
Gastrointestinal Effects
Human exposure to TCDD has been associated with
complaints of abdominal pain, vomiting, and diarrhea. Ad-
ministrationofTCDDtoafewspecies, suchasthemonkeyand
cow, produceshyperplastic changes inthegastrointestinal tract.
Suchfindingsarenotcommoninrodents, soitisnotsurprising
that the studies cited in this review revealed no evidence of
gastrointestinaleffectsassociatedwithadministrationofthebro-
minated compounds. Possible gastrointestinal effects due to
PBDD and PBDF exposure cannotbe ruled out.
Immunotoxicity
TCDD and TCDF (as well as other representatives ofthese
groups) havebeenrepeatedlydemonstrated topossessimmuno-
suppressantactivity inlaboratoryanimals, asreviewedby Dean
et al. (56) and Exon et al. (57). Evidence ofsimilar effects in
humans, however, islessconvincing. Itissuspected thatTCDD-
induced immunosuppression may be mediated through the
cytosolic Ah receptor (56). Given the similarities between the
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chloro and bromo analogs, it is likely that the brominated and
mixed PHDDsandPHDFs arealso immunoactivecompounds.
Suggestions for Future Research
Basedonthis reviewoftheavailableliteratureonPBDDsand
PBDFs, several areas forfuture research couldprovide impor-
tant insights into the environmental significance and tox-
icological importance ofthisclassofcompounds. a)Improved,
rapid quantitative and qualitative analytical procedures are re-
quired to better assess the magnitude of environmental con-
tamination bythecompounds. Methods shouldbedeveloped for
assay offumes, water, soil, andbiological samples. b) Studies
ofthe behavior ofthe brominated chemicals in the ecosystem
shouldbeconducted. Suchstudies shouldbedesignedtodeter-
minethe stability ofthechemicalsintheenvironmentandtheir
ability toaccumulateandconcentrateinthefoodchain. Preferen-
tial accumulation of specific congeners should be assessed.
Human fattssues shouldalsobeassayed forpresenceofthecom-
pounds. c) Because of the enormous number of mixed
halogenated derivatives possible, toxicity equivalency factors
shouldbevalidatedforthemembersofthisfamilyofcompounds.
TEFs mayalsobeemployed toconductstructure-activity rela-
tionship studies. d) Selected bromo and mixed compounds
shouldbeassessed forgenotoxicandimmunotoxicpotential. e)
Comparative toxicology studies between bromo, chloro, and
mixeddibenzo-p-dioxins anddibenzofurans shouldbeconducted
to gain insight into the role ofthe individual halogens in deter-
mining biological effects. These studies should include single
and repeated dosage regimens and include assessments ofthe
biological dispositionsofthechemicals. Studies shouldalsobe
designed todetermine effects onreproduction andfetaldevelop-
ment and potential carcinogenicity.
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